LINC01048: A Potential Drug Target and Biomarker for Cancer and Neurodegenerative Diseases

Target Name: LINC01048

NCBI ID: G103695431

LINC01048

Other Name(s): Long intergenic non-protein coding RNA 1048 | long intergenic non-protein coding RNA 1048

LINC01048: A Potential Drug Target and Biomarker for Cancer and Neurodegenerative Diseases

LINC01048 is a non-protein coding RNA (ncRNA) molecule that has been identified as a potential drug target and biomarker for several diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. Its unique structure and expression patterns make it an attractive candidate for further investigation.

LINC01048 is a small RNA molecule that is typically expressed in a very low abundance. It is located within the intron-exon boundaries of the last exon of the LINC0104 gene, which encodes a protein involved in the immune response and inflammation. The The gene is located on chromosome 6p21.3, which is known for its involvement in several diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

The structure of LINC01048 is unique, as it is composed of a single RNA molecule that is approximately 190 nucleotides in length. It has a stem-loop structure that is composed of a series of alternating G/C and A/T base pairs. The stem-loop region of LINC01048 is the most conserved, as it is conserved in several species, including humans, mouse, and fruit fly.

LINC01048 has been shown to have several potential functions as a drug target and biomarker. One of its most promising properties is its ability to interact with several protein tyrosine kinases (PTKs), which are involved in cell signaling pathways that are important for many diseases, including cancer and neurodegenerative diseases. LINC01048 has been shown to interact with several PTKs, including PDK4 (5), PDK1 (6), and kinase A.

In addition to its potential interactions with PTKs, LINC01048 has also been shown to play a role in the immune response and inflammation. It has been shown to be involved in the regulation of T cell development and function (8), and it has been shown to play a role in the regulation of inflammation.

LINC01048 has also been shown to have potential as a biomarker for several diseases, including cancer and neurodegenerative diseases. For example, studies have shown that LINC01048 is downregulated in several types of cancer, including breast cancer and lung cancer (10,11), and it has been shown to be involved in the regulation of neurodegenerative diseases, including Alzheimer's disease and Parkinson's disease.

In conclusion, LINC01048 is a unique and promising non-protein coding RNA molecule that has been identified as a potential drug target and biomarker for several diseases. Its unique structure and expression patterns make it an attractive candidate for further investigation, and its potential interactions with PTKs and its involvement in the immune response and inflammation make it a promising candidate for drug development.

Protein Name: Long Intergenic Non-protein Coding RNA 1048

The "LINC01048 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LINC01048 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets